A risk-to-benefit analysis for central venous catheters

Transfusion Science

Volumn 17, Issue 3, 1996, Pages 379-383

  Du Toit, J Michael G ^a   Kaftansky, Richard ^a   Wood, Lucille ^a   Jacobs, Peter ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Wynberg Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL VENOUS CATHETER; HUMAN; INTERNAL JUGULAR VEIN; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SUPERIOR CAVA VEIN; VASCULAR ACCESS;

EID: 0029792281     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-3886(96)00008-2     Document Type: Article

References (20)

1. Mueller BU, Skelton J, Callender DPE, et al: A prospective randomised trial comparing the infectious and noninfectious complications of an externalised catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992; 10:1943-1948.
2. Morrison SC, Jacobs P: Thrombocytopenia and subclavian cannulation. Br Med J 1978; 2:279-280.
3. Jacobs P, Jacobson J: A practical method for ensuring long-term venous access. J Roy Soc Med 1979; 72:263-265.
4. Fan ST: A safe technique for the insertion of Hickman catheter into the internal jugular vein. J Patenteral Enteral Nutr 1988; 12:223-224.
5. Dennis MJS, Hunter AE, Ryan JJ: Longterm indwelling silastic central venous catheters: clinical audit leading to improved surgical technique. J Roy Soc Med 1990; 8:620-622.
6. Thompson L: Central venous catheters for apheresis access. J Clin Apheresis 1992; 7:154-157.
7. Schwartz C, Henrickson KJ, Roghmann K, Powell K: Prevention of bacteremia attributed to luminal colonization of tunnelled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8:1591-1597.
8. Morrison VA, Peterson BA, Bloomfield CD: Nosocomial septicaemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy. Med Pediatr Oncol 1990; 18:209-216.
9. Gosbell IB. Central venous catheterrelated sepsis: epidemiology, pathogenesis, diagnosis, treatment and prevention. Intensive Care World Monitor 1994; 11: 55-58.
10. Conlan MG, Haire WD, Lieberman RP, Lund G, Kessinger A, Armitage JO: Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation. Bone Marrow Transplant 1991; 7: 235-240.
11. Lederle FA, Parenti CM, Berskow LC, Ellingson KJ: The idle intravenous catheter. Ann Intern Med 1992; 116: 737-738.
12. Hodgson WJB, Mercan S: Hemapheresis listening post. Optimal venous access. Transfus Sci 1991; 12:274-276.
13. Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED: A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148:871-875.
14. Madan M, Alexander DJ, McMahon MJ: Influence of catheter type on occurrence of thrombophlebitis during peripheral intravenous nutrition. Lancet 1992; 339: 101-103.
15. Birdwell BG, Yeager R, Whitsett TL: Pseudotumor cerebri. A complication of catheter-induced subclavian vein thrombosis. Arch Intern Med 1994; 154: 808-811.
16. Weidmann B, Hänseier T, Jiminez C, Niederle N: Tricuspid endocarditis induced by implantable venous access. J Clin Oncol 1994; 12:1103-1105.
17. Bern MM, Lokich JJ, Wallach SR, et al.: Very low dose of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990; 112: 423-428.
18. Uderzo C, D'Angelo P, Rizzari C, et al: Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies. Bone Marrow Transplant 1992; 9:113-117.
19. Farkas JC, Liu N, Bleriot JP, Chevret S, Goldstein FW, Carlet J: Single versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med 1992; 93:277-282.
20. Simmons JR, Buzdar AU, Ota DM, Marts K, Hortobagyi GN: Complications associated with indwelling catheters. Med Pediatr Oncol 1992; 20:22-25.